Channel: mRNA cancer vaccines

Inspired by: Katalin Karikó

An mRNA cancer vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response to treat cancer. Wikipedia (CC BY-SA 3.0)

    2023 Articles

    1 503 articles

    Clinical development of mRNA therapies against solid tumors

    Comment Section

    Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects

    • Dimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, …, Ioanna Gazouli, Christos Koutserimpas, George Samonis
    • None, 10.3390/vaccines11030636
    Comment Section

    Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses

    Comment Section

    Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history

    • Steve Pascolo, Steve Pascolo, Steve Pascolo, Steve Pascolo, Steve Pascolo, Steve Pascolo
    • Eur J Immunol, 10.1002/eji.202249941
    Comment Section

    Characterization of BNT162b2 mRNA to Evaluate Risk of Off-Target Antigen Translation

    • Himakshi K Patel, Kun Zhang, Rachael Utegg, …, Jeff Ryczek, David J Cirelli, Thomas F Lerch
    • J Pharm Sci, 10.1016/j.xphs.2023.01.007
    Comment Section

    An mRNA vaccine elicits STING-dependent antitumor immune responses

    Comment Section

    mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine

    Comment Section

    mRNA-based cancer therapeutics

    Comment Section

    mRNA vaccines for cancer immunotherapy

    • Yashavantha L Vishweshwaraiah, Nikolay V Dokholyan, Yashavantha L Vishweshwaraiah, …, Nikolay V Dokholyan, Yashavantha L Vishweshwaraiah, Nikolay V Dokholyan
    • Front Immunol, 10.3389/fimmu.2022.1029069
    Comment Section

    Progress in immunotherapy

    Comment Section

    2022 Articles

    162 articles

    Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines

    Comment Section

    Nurturing Deep Tech to Solve Social Problems: Learning from COVID-19 mRNA Vaccine Development

    Comment Section

    Lipid nanoparticle-based mRNA candidates elicit potent T cell responses

    • Ye Zeng, Oscar Escalona-Rayo, Renzo Knol, …, Renzo Knol, Alexander Kros, Bram Slütter
    • Biomater Sci, 10.1039/d2bm01581a
    Comment Section

    Identification of tumour antigens and immune subtypes in the development of an anti-cancer vaccine for endometrial carcinoma

    • Jianyang Feng, Hong He, Jianyang Feng, …, Hong He, Jianyang Feng, Hong He
    • Scand J Immunol, 10.1111/sji.13250
    Comment Section

    Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants

    • Na Fan, Kepan Chen, Rong Zhu, …, Shuaicheng Li, Yuquan Wei, Xiangrong Song
    • Sci Adv, 10.1126/sciadv.abq3500
    Comment Section

    Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects

    • Madhu Gupta, Abhishek Wahi, Priyanka Sharma, …, Polrat Wilairatana, Mohammed Rahmatullah, Veeranoot Nissapatorn
    • None, 10.3390/vaccines10122011
    Comment Section

    Improved cancer immunotherapy strategies by nanomedicine

    • Shuai Guo, Jie Feng, Zongheng Li, …, Xiaozhong Qiu, Yikai Xu, Zheyu Shen
    • Wiley Interdiscip Rev Nanomed Nanobiotechnol, 10.1002/wnan.1873
    Comment Section

    Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer

    • Qiang Xu, Ye Chen, Yuan Jin, …, Andreas M Kaufmann, Andreas E Albers, Xu Qian
    • Viruses, 10.3390/v14122824
    Comment Section

    Recent Advances in Lipid Nanoparticles for Delivery of mRNA

    Comment Section

    Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy

    Comment Section